MedPath

Transcranial Alternating Current Stimulation (tACS) as a novel treatment option: a proof of concept study in Adult Classic Galactosemia

Completed
Conditions
classic galactosemia
GALT deficiency
10027424
10028037
Registration Number
NL-OMON49032
Lead Sponsor
Medisch Universitair Ziekenhuis Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Patient group:
The patient may participate in the study, if they meet these criteria:
- Adult age: 18 years or older
- GALT enzyme activity below 10% and/or GALT gene severe disease causing
mutations
- Motor sequencing and/or word productions problems
- Documented motor and language impairments
- Capable of giving informed consent
- The participants are screened pre and post intervention using standardized
tests. Participants with abnormal scores in cognitive and/or motor domains are
eligible.

Control group:
Healthy controls are included if they meet the following criteria:
- Adult age: 18 years or older
- No motor, language and/or cognitive impairments
- Capable of giving informed consent

Exclusion Criteria

- Motor and language problems due to other causes
- Eczema
- Psoriasis
- Epilepsy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Language/speech task<br /><br>Reaction times and accuracy will be compared pre, during and post stimulation<br /><br>within the CG group and between groups. To validate a relation of theta and<br /><br>beta oscillation on language problems, we will compare the EEG theta and beta<br /><br>power spectrum of CG and healthy controls during the active language task and<br /><br>in resting state data. To investigate the relation between tACS and brain<br /><br>oscillation we will compare theta and beta power in pre and post stimulation<br /><br>EEG. To validate a relation of speech behavior and tACS we will investigate the<br /><br>relation of theta power pre-post difference and behavior pre-post difference in<br /><br>both groups of participants.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath